Eleven Therapeutics Announces $22 Million in Seed Funding
Round includes $9 Million from the Bill & Melinda Gates Foundation, aimed at ushering in the next generation of RNAi therapeutics
TEL AVIV, Israel and CAMBRIDGE, England, Aug 02, 2022 -- (Healthcare Sales & Marketing Network) -- Eleven Therapeutics, a ... Biopharmaceuticals, Venture Capital Eleven Therapeutics, nucleic acid therapeutics
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news
More News: Funding | Israel Health | Marketing | Middle East Health | Pharmaceuticals | Venture Capital